Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) announced it will release its fourth quarter and full year financial results on March 29, 2022, after market close. The company's management will host a conference call at 4:30 p.m. ET to discuss the results and recent corporate developments. The financial results will provide insights into the company's operational performance, which is critical for investors. The event will be accessible via a webcast, with a replay available on the company's website for 90 days.
Positive
- Scheduled release of fourth quarter and full year financial results on March 29, 2022.
- Management conference call offers opportunity for detailed insights into recent corporate developments.
Negative
- None.
News Market Reaction – MOTS
In the trading session that priced this news, MOTS gained 1.14%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year financial results on Tuesday, March 29, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
| Conference Call and Webcast | ||
| Date and Time: | Tuesday, March 29that 4:30 p.m. ET | |
| Domestic: | 877-407-0792 | |
| International: | 201-689-8263 | |
| Passcode: | 13727501 | |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1533147&tp_key=9ce5b7fd09 | |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com
